E07.1
Dyshormogenetic goiter
Clinical Classification Guidelines
Inclusion Terms
- Dyshormonogenetic goiter
- Familial dyshormogenetic goiter
- Familial dyshormonogenetic goiter
- Pendred's syndrome
Excludes Type 1
- transitory congenital goiter with normal function (P72.0)
Medical Intelligence & Overview
Dyshormogenetic goiter, classified under ICD-10 code E07.1, is a type of thyroid enlargement caused by abnormal development or function of the thyroid gland. Unlike other forms of goiter, where iodine deficiency or autoimmune reactions are primary factors, dyshormogenetic goiter results from issues with hormone synthesis within the thyroid tissue. It can be inherited, particularly in familial cases, and may be associated with syndromes such as Pendred's syndrome. Recognizing this condition involves understanding its causes, symptoms, diagnosis methods, and available management strategies.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting thyroid hormone synthesis pathways Inheritance in familial patterns, passing down abnormal genes Associated syndromes like Pendred's syndrome, which involves genetic alterations impacting thyroid function and ear development Developmental anomalies during thyroid gland formation Potential environmental influences that may exacerbate underlying genetic factors
Key Symptoms: Gradual enlargement of the thyroid gland (goiter) Possible compression symptoms such as difficulty swallowing or a sensation of fullness in the neck Hoarseness or changes in voice if the goiter presses on nearby nerves In some cases, signs of hypothyroidism, including fatigue, weight gain, or cold intolerance In children, potential developmental delays or growth issues In familial cases, symptoms may be evident at a younger age
Diagnostic & Treatment
Diagnosis Path: Diagnosis of dyshormogenetic goiter involves a combination of clinical evaluation and laboratory testing. Healthcare providers typically perform a physical examination to assess thyroid size and position. Blood tests measure levels of thyroid hormones (T3 and T4) and thyroid-stimulating hormone (TSH) to evaluate thyroid function. Imaging studies such as ultrasound help determine the goiter's size and nodularity. In certain cases, genetic testing may be employed to identify mutations associated with familial forms or syndromes like Pendred's syndrome. Fine-needle aspiration biopsy might be indicated if suspicious nodules are present to rule out malignancy.
Treatment Protocols: Observation and regular monitoring for small, asymptomatic goiters Thyroid hormone replacement therapy to normalize hormone levels and potentially reduce gland size Surgical intervention such as thyroidectomy if the goiter causes significant symptoms or compresses nearby structures Treatment of associated syndromes like Pendred's syndrome with multidisciplinary care Addressing any hypothyroidism symptoms with appropriate medications Genetic counseling for affected families to understand inheritance patterns and implications
Clinical Advice & FAQs
Billing Guidance
Is E07.1 a billable ICD-10 code?
Yes, E07.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E07.1?
Clinical documentation must specify the nature of Dyshormogenetic goiter and any associated comorbidities for accurate reporting.
Cite this Clinical Reference